Financial Times Healthcare
Xbox regains lead in console battle
Microsoft's Xbox 360 led console sales in the US last month for the first time in more than two years as Nintendo continued to suffer supply problems for the Wii...
Patients' groups distrust 'big pharma'
Detailed rankings compiled from patient groups showed many continental European groups rated highly, while US and UK businesses were less well judged
Patients' groups distrust 'big pharma'
The majority of patients' organisations consider pharmaceutical companies untrustworthy, according to a survey conducted by a UK-based consultancy to be released...
Interest mounts in taking a Swiss view
A sudden surge in inquiries from finance, manufacturing and pharmaceutical companies wanting to move jobs to Switzerland has been triggered partly by a revolt over the...
More companies go for Swiss move
A surge in inquiries from finance, manufacturing and pharmaceutical companies wanting to move jobs to Switzerland has been triggered partly by a revolt over the 50p...
DFID cash boost for vaccines fund
The Department for International Development (DFID) has given £150m over the next decade to support the Global Alliance on Vaccines and Immunisations, a United...
AstraZeneca ties up with Indian drugmaker
The alliance with Torrent Pharmaceuticals is the first step in the Anglo-Swedish pharmaceutical group's plans to rapidly expand sales of generic drugs
Pay is frozen for 120,000 senior staff in public sector
An ice age for public-sector pay - at least for more senior staff - began yesterday with the government announcing a freeze from April for almost 120,000 high-ranking...
Blow to Ark Therapeutics
Ark Therapeutics was among the biggest small-cap fallers yesterday. Its shares dropped 11.1 per cent to 11½p after the biotechnology company said it had...
Sanofi joins Merck in animal health venture
Sanofi-Aventis of France yesterday paid $1bn to Merck of the US as part of a deal to establish a joint venture which will be the world's largest animal health...
Insurers plan ads blitz on health reform
The US Chamber of Commerce and the insurance industry are to mount a final offensive in their fight against healthcare reform with a multi-million dollar advertising...
Sanofi joins Merck in animal health venture
The pharmaceutical group has agreed a deal to establish a joint venture with Merck which will be the world's largest animal health business
Bupa's Asia growth mitigates UK, US slowness
Strong growth in customer numbers in Asia and the acquisition of MBF, the Australian insurer, helps mitigate sluggish performance of the medical insurance group in the US and UK
Sanofi and Merck to combine animal divisions
French and US pharmaceutical groups agree to join their animal health operations, creating a joint venture with nearly $5.3bn in annual sales
Regulator finds ethics breach by AstraZeneca
AstraZeneca failed to reflect accurately the side-effects of its top-selling anti-psychotic drug, Seroquel, in an advertisement to doctors, a UK regulatory panel has...
Intertek buoyed by increase in product testing
Ongoing product recalls, such as those by Toyota of more than 8m cars, are likely to spur companies to outsource further testing to third parties, the chief executive...
AstraZeneca job cuts reflect new landscape for drug innovation
When AstraZeneca revealed details last week of 3,500 job cuts across its global research and development operations, it was not just the company's own employees who...
Healthcare insurers forced to drop deal
The Obama administration dealt another blow to the insurance industry yesterday after it forced two Michigan companies to abandon plans for a deal because of antitrust...
Regulator finds ethics breach by AstraZeneca
A UK regulatory panel says the pharmaceutical group failed to accurately reflect the side effects of its top-selling antipsychotic drug Seroquel in an advertisement to doctors
AstraZeneca job cuts reflect new landscape
Anglo-Swedish pharmaceuticals group's move is latest in series of shake-ups that will have a key impact on the volume of medical innovation